03/24 StreetInsider.com Pre-Open Movers
Tweet
Share
E-mailGet Alerts AGEN Hot Sheet
Join SI Premium – FREE
03/24 StreetInsider.com Pre-Open Movers:
Antigenics Inc. (NASDAQ: AGEN) 46% LOWER; Said Phase 3 Results for Oncophage in Kidney Cancer Did Not Meet Endpoints
Matritech Inc. (AMEX: MZT) 40% HIGHER; NMP22(R) BladderChek(R) Test Detected 100% of Dangerous Tumors in Women at Risk for Bladder Cancer
Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) 26% LOWER; Modifies Clinical Development of Valopicitabine for Hepatitis C
WatchGuard Technologies Inc. (Nasdaq: WGRD) 17% HIGHER; WatchGuard Holder Vector Said Company Should Consider Sale - 13D
Cephalon Inc. (Nasdaq: CEPH) 14.9% LOWER; FDA panel rejects Cephalon (CEPH) ADHD drug SPARLON
Lucent Technologies Inc. (NYSE: LU) 12.4% HIGHER; Confirms Merger Talks with Alcatel (ALA)
Aehr Test Systems (Nasdaq: AEHR) 11% HIGHER; reports Q3 results
Google Inc. (Nasdaq: GOOG) 8% HIGHER; Added to The S&P 500
Wet Seal Inc. (Nasdaq: WTSLA) 7% LOWER; reports Q4 results
Senomyx Inc. (Nasdaq: SNMX) 5.7% HIGHER; Announces Expansion and Amendment of Collaboration with Nestle SA
Palm, Inc. (Nasdaq: PALM) 5.5% HIGHER; Tops Q3 EPS By 3c, Guides Above
Tuesday Morning Corp. (Nasdaq: TUES) 5.7% HIGHER; will replace UICI (NYSE: UCI) in the S&P SmallCap 600
SMART Modular (Nasdaq: SMOD) 5% LOWER; reports Q2 results
Alcatel (NYSE: ALA) 4.6% HIGHER; merger talks with Lucent
Prudential plc (NYSE: PUK) 4.5% LOWER; Aviva withdraws proposed merger
3Com Corporation (Nasdaq: COMS) 4% HIGHER; reports Q3 results
Matria Healthcare Inc. (Nasdaq: MATR) 3.9% HIGHER; will replace Hughes Supply Inc. (NYSE: HUG) in the S&P SmallCap 600
Encysive Pharmaceuticals Inc. (Nasdaq: ENCY) 3.9% LOWER; ENCY and FDA Place TBC3711 Clinical Studies on Hold
SiRF Technology Holdings Inc. (Nasdaq: SIRF) 3% HIGHER; Jim Cramer Highlights SiRF Technology (SIRF) on Mad Money
Solectron Corp. (NYSE: SLR) 2% HIGHER; reports Q2 results
Antigenics Inc. (NASDAQ: AGEN) 46% LOWER; Said Phase 3 Results for Oncophage in Kidney Cancer Did Not Meet Endpoints
Matritech Inc. (AMEX: MZT) 40% HIGHER; NMP22(R) BladderChek(R) Test Detected 100% of Dangerous Tumors in Women at Risk for Bladder Cancer
Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) 26% LOWER; Modifies Clinical Development of Valopicitabine for Hepatitis C
WatchGuard Technologies Inc. (Nasdaq: WGRD) 17% HIGHER; WatchGuard Holder Vector Said Company Should Consider Sale - 13D
Cephalon Inc. (Nasdaq: CEPH) 14.9% LOWER; FDA panel rejects Cephalon (CEPH) ADHD drug SPARLON
Lucent Technologies Inc. (NYSE: LU) 12.4% HIGHER; Confirms Merger Talks with Alcatel (ALA)
Aehr Test Systems (Nasdaq: AEHR) 11% HIGHER; reports Q3 results
Google Inc. (Nasdaq: GOOG) 8% HIGHER; Added to The S&P 500
Wet Seal Inc. (Nasdaq: WTSLA) 7% LOWER; reports Q4 results
Senomyx Inc. (Nasdaq: SNMX) 5.7% HIGHER; Announces Expansion and Amendment of Collaboration with Nestle SA
Palm, Inc. (Nasdaq: PALM) 5.5% HIGHER; Tops Q3 EPS By 3c, Guides Above
Tuesday Morning Corp. (Nasdaq: TUES) 5.7% HIGHER; will replace UICI (NYSE: UCI) in the S&P SmallCap 600
SMART Modular (Nasdaq: SMOD) 5% LOWER; reports Q2 results
Alcatel (NYSE: ALA) 4.6% HIGHER; merger talks with Lucent
Prudential plc (NYSE: PUK) 4.5% LOWER; Aviva withdraws proposed merger
3Com Corporation (Nasdaq: COMS) 4% HIGHER; reports Q3 results
Matria Healthcare Inc. (Nasdaq: MATR) 3.9% HIGHER; will replace Hughes Supply Inc. (NYSE: HUG) in the S&P SmallCap 600
Encysive Pharmaceuticals Inc. (Nasdaq: ENCY) 3.9% LOWER; ENCY and FDA Place TBC3711 Clinical Studies on Hold
SiRF Technology Holdings Inc. (Nasdaq: SIRF) 3% HIGHER; Jim Cramer Highlights SiRF Technology (SIRF) on Mad Money
Solectron Corp. (NYSE: SLR) 2% HIGHER; reports Q2 results
You May Also Be Interested In
- Marvell signs major custom silicon deal with Google, sell-side comments
- Premarket movers: Crypto stocks rally, Ross Stores jump on upbeat forecast
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
General News, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
